Results of a Phase 3 randomised multicenter study comparing pixantrone+ rituximab with gemcitabine+ rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma …
user-5fe1a78c4c775e6ec07359f9（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要